Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Plos One
|
May 17, 2019
Role of efavirenz plasma concentrations on long-term HIV suppression and immune restoration in HIV-infected children
Nontiya Homkham, Tim R Cressey, Naim Bouazza, et al.
AIDS (London, England)
|
May 31, 2013
A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients
Naïm Bouazza, Jean-Marc Tréluyer, Philippe Msellati, et al.
Antimicrobial Agents and Chemotherapy
|
July 8, 2009
Didanosine population pharmacokinetics in West African human immunodeficiency virus-infected children administered once-daily tablets in relation to efficacy after one year of treatment
Déborah Hirt, Christophe Bardin, Serge Diagbouga, et al.
Clinical Pharmacokinetics
|
October 17, 2022
Meropenem Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy
Michael Thy, Saik Urien, Naim Bouazza, et al.
The Journal of Antimicrobial Chemotherapy
|
September 28, 2014
Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy
Tim R Cressey, Saik Urien, Edmund V Capparelli, et al.
The Pediatric Infectious Disease Journal
|
July 31, 2015
Efavirenz Concentrations and Probability of HIV Replication in Children
Nontiya Homkham, Tim R Cressey, Naïm Bouazza, et al.
Journal of Clinical Pharmacology
|
January 11, 2016
A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based Regimens
Nontiya Homkham, Tim R Cressey, Lily Ingsrisawang, et al.
Antimicrobial Agents and Chemotherapy
|
June 3, 2010
Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children?
Naïm Bouazza, Déborah Hirt, Christophe Bardin, et al.
Antimicrobial Agents and Chemotherapy
|
July 8, 2015
Population approach to analyze the pharmacokinetics of free and total lopinavir in HIV-infected pregnant women and consequences for dose adjustment
Floris Fauchet, Jean-Marc Treluyer, Silvia M Illamola, et al.
British Journal of Clinical Pharmacology
|
May 14, 2011
Lopinavir/ritonavir population pharmacokinetics in neonates and infants
Saik Urien, Ghislaine Firtion, Suzanne T Anderson, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Plos One
|
May 17, 2019
Role of efavirenz plasma concentrations on long-term HIV suppression and immune restoration in HIV-infected children
Nontiya Homkham, Tim R Cressey, Naim Bouazza, et al.
AIDS (London, England)
|
May 31, 2013
A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients
Naïm Bouazza, Jean-Marc Tréluyer, Philippe Msellati, et al.
Antimicrobial Agents and Chemotherapy
|
July 8, 2009
Didanosine population pharmacokinetics in West African human immunodeficiency virus-infected children administered once-daily tablets in relation to efficacy after one year of treatment
Déborah Hirt, Christophe Bardin, Serge Diagbouga, et al.
Clinical Pharmacokinetics
|
October 17, 2022
Meropenem Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy
Michael Thy, Saik Urien, Naim Bouazza, et al.
The Journal of Antimicrobial Chemotherapy
|
September 28, 2014
Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy
Tim R Cressey, Saik Urien, Edmund V Capparelli, et al.
The Pediatric Infectious Disease Journal
|
July 31, 2015
Efavirenz Concentrations and Probability of HIV Replication in Children
Nontiya Homkham, Tim R Cressey, Naïm Bouazza, et al.
Journal of Clinical Pharmacology
|
January 11, 2016
A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based Regimens
Nontiya Homkham, Tim R Cressey, Lily Ingsrisawang, et al.
Antimicrobial Agents and Chemotherapy
|
June 3, 2010
Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children?
Naïm Bouazza, Déborah Hirt, Christophe Bardin, et al.
Antimicrobial Agents and Chemotherapy
|
July 8, 2015
Population approach to analyze the pharmacokinetics of free and total lopinavir in HIV-infected pregnant women and consequences for dose adjustment
Floris Fauchet, Jean-Marc Treluyer, Silvia M Illamola, et al.
British Journal of Clinical Pharmacology
|
May 14, 2011
Lopinavir/ritonavir population pharmacokinetics in neonates and infants
Saik Urien, Ghislaine Firtion, Suzanne T Anderson, et al.
Page
of 7